Compare Adaptive Biotechnologies Corp (ADPT) vs Packaging Corporation of America (PKG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Packaging Corporation of America — how do they compare? Adaptive Biotechnologies Corp trades at $19.99 (market cap $3.33B), while Packaging Corporation of America trades at $225.73 (market cap $20.71B). The key difference: Packaging Corporation of America is far larger — about 6.2× Adaptive Biotechnologies Corp's market cap, and Packaging Corporation of America pays a 2.58% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | PKG | |
|---|---|---|
Market Cap | $3.33B | $20.71B |
Sector | Health | Technology |
52-Week High | $22.37 | $246.31 |
52-Week Low | $10.24 | $191.41 |
Enterprise Value | $3.19B | $24.53B |
Dividend Yield | — | 2.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADPT trades at $20.82, down 1.75% today, with a bullish technical signal from moving averages and a consensus analyst price target of $20.40. The company announced a strategic separation of its MRD and Immune Medicine businesses in June 2026, alongside a $300 million convertible notes offering to enhance financial flexibility. Revenue grew to $277 million in 2025, though net losses persist at -$59.50 million, with improving margins and cash flow trends showing net positive cash generation of $22.37 million.
Outlook remains cautiously optimistic as the business split aims to unlock value, but execution risks and sustained profitability challenges pose headwinds. Analysts are predominantly bullish (64.71% buy ratings), citing growth in the clonoSEQ MRD segment, yet the stock faces volatility from high valuation multiples and insider selling activity.
Packaging Corporation of America (PKG) trades at $236.39, down 0.76% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported a Q1 2026 EPS beat of $2.40 versus $2.14 expected, with revenue growth to $2.4 billion. Recent news highlights a 20% dividend increase to an annual $6.00 per share and upcoming Q2 2026 earnings call on July 23, 2026.
PKG presents a mixed outlook with strong profitability metrics like a 16.21% ROE and 8.04% net margin, but faces margin pressure and two recent earnings misses. The consensus price target of $245 suggests modest upside, though risks include input cost inflation and competitive pressures. Institutional sentiment is cautiously optimistic with 38% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →
